Literature DB >> 35013583

HAIC-FO improves outcomes in HCC.

Peter Sidaway1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35013583     DOI： 10.1038/s41571-022-00599-0

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  1 in total

1.  Arterial Chemotherapy of Oxaliplatin Plus Fluorouracil Versus Sorafenib in Advanced Hepatocellular Carcinoma: A Biomolecular Exploratory, Randomized, Phase III Trial (FOHAIC-1).

Authors:  Ning Lyu; Xun Wang; Ji-Bin Li; Jin-Fa Lai; Qi-Feng Chen; Shao-Long Li; Hai-Jing Deng; Meng He; Lu-Wen Mu; Ming Zhao
Journal:  J Clin Oncol       Date:  2021-12-14       Impact factor: 50.717
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.